Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen

NCT03279289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Aflibercept
DRUG: Irinotecan
DRUG: folinic acid (dl racemic)
DRUG: 5Fluorouracil
DRUG: 5-FU

Sponsor

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Collaborators

[object Object]